These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6122056)

  • 21. Chloroquine and sulfadoxine/pyrimethamine sensitivity in Burkina Faso. In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in Burkina Faso.
    Del Nero L; Nebie I; Soudouem G; Pietra V
    Trop Geogr Med; 1994; 46(1):8-10. PubMed ID: 8165742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmodium falciparum resistant to mefloquine plus sulfadoxine/pyrimethamine.
    Heizmann P; Fernex M; Leimer R; Reber-Liske R; Stohler H
    Lancet; 1986 Feb; 1(8477):377. PubMed ID: 2868309
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro susceptibility of Plasmodium falciparum malaria to pyrimethamine, sulfadoxine, trimethoprim and sulfamethoxazole, singly and in combination.
    Petersen E
    Trans R Soc Trop Med Hyg; 1987; 81(2):238-41. PubMed ID: 3303480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fansidar-resistant falciparum malaria in Papua New Guinea.
    Darlow B; Vrbova H; Stace J; Heywood P; Aalpers M
    Lancet; 1980 Dec; 2(8206):1243. PubMed ID: 6108409
    [No Abstract]   [Full Text] [Related]  

  • 25. Pyrimethamine/sulfadoxine resistant falciparum malaria in East Africa.
    Timmermanns PM; Hess U; Jones ME
    Lancet; 1982 May; 1(8282):1181. PubMed ID: 6122952
    [No Abstract]   [Full Text] [Related]  

  • 26. Standard and reduced doses of sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum in Tanzania, with determination of drug concentrations and susceptibility in vitro.
    Hellgren U; Kihamia CM; Bergqvist Y; Lebbad M; Premji Z; Rombo L
    Trans R Soc Trop Med Hyg; 1990; 84(4):469-72. PubMed ID: 2091329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Fansidar against Plasmodium falciparum in continuous culture.
    Brockelman CR; Tan-Ariya P
    Am J Trop Med Hyg; 1982 Sep; 31(5):913-8. PubMed ID: 6751112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Resistance of Plasmodium falciparum to fansidar, quinine and tetracycline].
    Alencar FH; Ferraroni JJ; Shrimpton R
    Rev Saude Publica; 1982 Oct; 16(5):299-302. PubMed ID: 6762641
    [No Abstract]   [Full Text] [Related]  

  • 29. [Chloroquine- and fansidar-resistant falciparum malaria treated with minocycline].
    Ferraroni JJ
    Rev Saude Publica; 1983 Aug; 17(4):328-31. PubMed ID: 6361974
    [No Abstract]   [Full Text] [Related]  

  • 30. Mefloquine and sulfadoxine/pyrimethamine resistant Plasmodium falciparum.
    Arnold K
    Lancet; 1986 Jan; 1(8473):154. PubMed ID: 2867368
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of chloroquine, amodiaquine and pyrimethamine-sulfadoxine on Plasmodium falciparum gametocytemia.
    Strickland GT; Fox E; Sarwar M; Khaliq AA; Macdonald M
    Am J Trop Med Hyg; 1986 Mar; 35(2):259-62. PubMed ID: 3513644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The activity of pyrimethamine and sulphadoxine against Plasmodium falciparum determined by the in vitro microtechnique.
    Eastham GM; Rieckmann KH
    Trans R Soc Trop Med Hyg; 1983; 77(1):91-3. PubMed ID: 6344364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Falciparum malaria resistant to chloroquine, quinine and Fansidar in a non-immune patient infected in Ghana.
    Nguyen C; Gregson D; Mouldey P; Keystone JS
    Trans R Soc Trop Med Hyg; 1989; 83(4):485-6. PubMed ID: 2694485
    [No Abstract]   [Full Text] [Related]  

  • 34. The therapeutic efficacy of sulfadoxine/pyrimethamine against Plasmodium falciparum in Yemen.
    Al-Kabsi AM; Al-Shamahy HA; Al-Harazy AH; Harmal NS
    Med Princ Pract; 2009; 18(1):62-6. PubMed ID: 19060494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand.
    Hurwitz ES; Johnson D; Campbell CC
    Lancet; 1981 May; 1(8229):1068-70. PubMed ID: 6112445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amodiaquine and sulfadoxine-pyrimethamine as treatment for chloroquine-resistant Plasmodium falciparum in Rwanda.
    Deloron P; Sexton JD; Bugilimfura L; Sezibera C
    Am J Trop Med Hyg; 1988 Mar; 38(2):244-8. PubMed ID: 3281489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal concentration of p-aminobenzoic acid and folic acid in the in vitro assay of antifolates against Plasmodium falciparum.
    Tan-ariya P; Brockelman CR; Menabandhu C
    Am J Trop Med Hyg; 1987 Jul; 37(1):42-8. PubMed ID: 3300393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro.
    Chulay JD; Watkins WM; Sixsmith DG
    Am J Trop Med Hyg; 1984 May; 33(3):325-30. PubMed ID: 6375404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
    Djaman J; Abouanou S; Basco L; Koné M
    Sante; 2004; 14(4):205-9. PubMed ID: 15745869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response of Plasmodium falciparum to dihydrofolate reductase inhibitors in Malindi, Kenya.
    Spencer HC; Watkins WW; Sixsmith DG; Koech DK
    Trans R Soc Trop Med Hyg; 1986; 80(2):201-3. PubMed ID: 3538522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.